Nicholas R Livingston
Overview
Explore the profile of Nicholas R Livingston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nowell J, Raza S, Livingston N, Sivanathan S, Gentleman S, Edison P
J Alzheimers Dis
. 2024 Sep;
101(3):987-999.
PMID: 39302365
Background: Tau aggregation demonstrates close associations with hypometabolism in Alzheimer's disease (AD), although differing pathophysiological processes may underlie their development. Objective: To establish whether tau deposition and glucose metabolism have...
2.
Livingston N, Stanton K
Personal Ment Health
. 2024 Sep;
18(4):402-413.
PMID: 39258431
Borderline personality disorder (BPD) is characterized by affective, interpersonal, and identity instability, as well as marked impulsivity. There is evidence that BPD may be best operationalized dimensionally using models such...
3.
Berry K, Livingston N, Briles E, Looby A
Cannabis
. 2024 Jun;
6(4):67-81.
PMID: 38883283
Objective: College students high in social anxiety are at increased risk for cannabis-related problems. This may be particularly true when they hold strong coping-related expectancies and motives for cannabis. However,...
4.
Livingston N, Kiemes A, Devenyi G, Knight S, Lukow P, Jelen L, et al.
Neuropsychopharmacology
. 2024 Apr;
49(9):1448-1458.
PMID: 38658738
Elevated hippocampal perfusion has been observed in people at clinical high risk for psychosis (CHR-P). Preclinical evidence suggests that hippocampal hyperactivity is central to the pathophysiology of psychosis, and that...
5.
Livingston N, De Micheli A, McCutcheon R, Butler E, Hamdan M, Grace A, et al.
Schizophr Bull
. 2024 Apr;
51(2):446-457.
PMID: 38567823
Background And Hypothesis: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences...
6.
Livingston N, Fusar-Poli P, Modinos G
Psychol Med
. 2023 Nov;
54(1):215-216.
PMID: 37921000
No abstract available.
7.
Looby A, Piccorelli A, Zimmerman L, Falco C, Livingston N, Akin C, et al.
Psychopharmacology (Berl)
. 2023 Sep;
241(1):109-118.
PMID: 37740001
Rationale: Nonmedical prescription stimulant use (NPS; use without a prescription or in ways other than prescribed) is common among college students. Despite the potential for negative consequences, students continue engaging...
8.
Livingston N, De Micheli A, McCutcheon R, Butler E, Hamdan M, Grace A, et al.
medRxiv
. 2023 Aug;
PMID: 37645948
Background: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences the risk...
9.
Livingston N, Berry K, Meier E, Looby A
Subst Use Misuse
. 2023 Apr;
58(8):989-995.
PMID: 37077031
: Concurrent alcohol and cannabis (i.e. marijuana) use (CAM; use of both substances within the same specified time frame) is prevalent among college students and associated with increased risk of...
10.
Looby A, Prince M, Livingston N, Berry K
Addict Behav
. 2023 Apr;
144:107718.
PMID: 37059000
The risk for cannabis-related problems is elevated among young adults with attention-deficit/hyperactivity disorder (ADHD) symptoms. It is unknown whether the use of cannabis protective behavioral strategies (PBS) mitigates this risk...